Innovita Biological Technology Past Earnings Performance
Past criteria checks 5/6
Innovita Biological Technology has been growing earnings at an average annual rate of 2.9%, while the Medical Equipment industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 60.7% per year. Innovita Biological Technology's return on equity is 15.2%, and it has net margins of 44.8%.
Key information
2.9%
Earnings growth rate
-13.2%
EPS growth rate
Medical Equipment Industry Growth | 16.0% |
Revenue growth rate | 60.7% |
Return on equity | 15.2% |
Net Margin | 44.8% |
Next Earnings Update | 26 Oct 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Innovita Biological Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 676 | 303 | 134 | 75 |
31 Mar 24 | 625 | 266 | 134 | 65 |
31 Dec 23 | 478 | 174 | 104 | 53 |
30 Sep 23 | 487 | 149 | 107 | 62 |
30 Jun 23 | 420 | 120 | 102 | 61 |
31 Mar 23 | 512 | 178 | 101 | 71 |
31 Dec 22 | 447 | 151 | 97 | 72 |
30 Sep 22 | 373 | 143 | 86 | 57 |
30 Jun 22 | 360 | 133 | 79 | 49 |
31 Mar 22 | 267 | 78 | 81 | 36 |
31 Dec 21 | 327 | 120 | 84 | 31 |
31 Dec 20 | 1,037 | 571 | 153 | 59 |
31 Dec 19 | 138 | 21 | 66 | 21 |
31 Dec 18 | 79 | 17 | 34 | 11 |
Quality Earnings: 688253 has high quality earnings.
Growing Profit Margin: 688253's current net profit margins (44.8%) are higher than last year (28.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688253's earnings have grown by 2.9% per year over the past 5 years.
Accelerating Growth: 688253's earnings growth over the past year (153.3%) exceeds its 5-year average (2.9% per year).
Earnings vs Industry: 688253 earnings growth over the past year (153.3%) exceeded the Medical Equipment industry -8.6%.
Return on Equity
High ROE: 688253's Return on Equity (15.2%) is considered low.